| Editor |
Kew Kim Chew |
| Publications
Committee |
Kew Kim Chew (Chair)
Yasusuke Kimoto
Wah Yun Low
Wanchai Nairayaksaree |
Executive Council (EXCO) 2005-2007 |
| President |
Akihiko Okuyama |
| President-Elect |
Han Sun Chiang |
| Immediate Past President |
Sae-Chul Kim |
| Secretary-General |
Hui Meng Tan |
| Treasurer |
Apichat Kongkanand |
Click here to download the News
Bulletin --> PDF 1.1Mb
APSSM Objectives
- To improve standards of clinical care and quality
of life for patients suffering from sexual dysfunction in Asia Pacific
countries
- To encourage scientific research to benefit the
general public in Asia Pacific countries
- To serve as an information resource and
communication base between member countries
- To promote fellowship of its membership
- To promote an international drive to improve the
quality of life of men and women with sexual dysfunction in the world
- To ensure that the Society’s activities are not of
a political nature and that no profit is made by the Society
Message from the Editor
The
Asia Pacific Society for Sexual Medicine (APSSM) is proud to publish
this First Issue of its very own bi-annual APSSM Newsletter.
In addition to being an effective medium of
communication between the Executive Council and members of the Society
and providing an important interface between the Society and the general
medical and para-medical fraternities, the APSSM Newsletter will promote
fellowship within its membership and enhance its bonding.
APSSM is the peak organisation for sexual medicine for
the Asia Pacific region, which sustains 60% of the world’s population
with diverse ethnic, cultural and religious backgrounds, tradition and
practice. It is one of the oldest societies dedicated to research and
education in sexual medicine.
It is hoped that the Newsletter will serve as a record
of the robust activities of the Society, a notice board for the
announcement of upcoming events, a forum for the free expression of
views, and an archive for research and educational articles.
Columns such as “Letter to the Editor” and “As I was
saying…” will be interesting add-ons whenever demands occur.
Comments and suggestions are welcome. Please send all
correspondence and submissions to the Editor at:
kewkimchew@hotmail.com.
APSSM News Bulletin APSSM News Bulletin Issue 1 2006
APSSM Activities
Information regarding APSSM, its activities and its recent announcements
can be accessed at the APSSM website:
www.apsir.org.
The following are the highlights from the
Secretary-General’s report and the reports of various Committee Chairs:
Secretariat
Secretary-General: Hui Meng Tan
- Draft copy of new by-laws is being considered by
the Executive Council.
- Organisation of the 2nd APSSM Regional Scientific
Meeting in India in December 2006 is in progress. The 3rd Scientific
Meeting will be held in 2008 in China.
- Collection of APSSM and International Society for
Sexual Medicine (ISSM) membership fees is well in hand. Deadline for
payment has been extended to end of February 2006.
- Six Local Conference Grants are available for 2006.
- APSSM website has been updated.
- APSSM Financial Report for 2005 and Budget for 2006
have been submitted to ISSM.
- Nine APSSM Research Grants were awarded for 2005.
- The 11th Biennial Meeting of APSSM will be held in
Korea in 2007, and the 12th Biennial Meeting in Singapore.
Audit Committee
Chair: Sudhakar Krishnamurti
- Recommendations were made regarding foreign
exchange charges and quotations for projects.
Scientific and Research
Committee
Chair: Kwang Sung Park
- The four awardees of the 2005 APSSM Travel Grants
of USD3,000 each, selected from nine applications, were: Sudhakar
- Details of 2006 APSSM Travel and Research Grants
are available at APSSM website.
By-Laws Committee
Chair: Peter Lim
- Draft copy of new by-laws is being considered by
the Executive Council.
Website Committee
Chair: Sung Won Lee
- Ways of improving and updating current website will
be considered.
Membership Committee
Chair: Han Sun Chiang
- Strategies for membership drive are being
considered.
- APSSM membership at a special rate comes with
membership of ISSM and all the privileges of both Societies.
Krishnamurti, Jihong Liu, Srilatha Balasubramaniam and Wah Yun Low.
- Nine APSSM Research Grants of USD5,000 each were
awarded for 2005 and were as follows:
|
Awardee |
Research Project |
| Akira Tsujimura |
Brain activation specific for
sexual arousal. |
| Bumsik Hong |
Atorvastatin augments vascular
endothelial growth factor expression in diabetic rat penile
tissue. |
| Bang Ping Jiann |
Sexual dysfunction in male drug
abusers. |
| Sun Won Lee |
In vivo transfection of dominant
negative form of transient
receptor protein channel (TRPC6) in diabetic rats. |
| Jihong Liu |
The effect of siRNAs targeting the
phosphodiesterase 5 (PDE 5) gene on erectile function in rats. |
| Ki-Hak Moon |
The mechanisms of action of
metformin on the recovery of the penile nitric oxide synthase in
high fat fed obese rats. |
| Zhong Cheng Xin |
Study of the effects of Icariin on
erectile dysfunction (ED) in a diabetes rat model. |
| Kew Kim Chew |
1. To assess the efficacy and
safety of combination pharmaco-therapy for ED, using oral PDE 5
inhibitor and intracavernosal injection of prostaglandin E1, in
men with ED who had failed treatment with these medications when
either was used alone.
2. To assess the value of ED as a predictor of
cardiovascular disease. |
Development Committee
Chair: Ken Marumo
- Six grants of USD 5,000 each are available for
travel to relevant national conferences on sexual medicine and men’s
health.
Publications Committee
Chair: Kew Kim Chew
- Regular updates on APSSM activities were provided
for the ISSM Newsbulletin.
- A similar update was published in the Asian Journal
of Andrology.
- An update on APSSM activities and a report on the
9th Biennial Meeting of the Society were published in Issue 11 of the
InformED Newsletter.
- The Committee was charged with the responsibility
of publishing the APSSM Newsletter biannually.
The 10th Biennial Meeting of APSSM
The 10th Biennial Meeting of APSSM was held at the internationally
acclaimed Cairns Convention Centre on 4th to 8th October 2005 in the
resort city of Cairns in Australia. It was hosted by the Keogh Institute
for Medical Research, which is based in Perth, Australia. Carolyn Earle
was Chair of the Organising Committee, with the awardwinning Promaco
Conventions as conference organisers. Kim Chew was in charge of the
Scientific Programme, and the Faculty included a panel of international
opinion leaders in sexual medicine, in addition to the invited plenary
and symposium speakers.
The Scientific Programme with the theme ‘Old Problems
– New Solutions’ comprised:
(a) 12 plenary lectures on a wide range of topical
issues
(b) 4 issue-specific symposia complemented by symposia presented by
the Asia Pacific Society for the Study of the Aging Male (APSSAM),
Andrology Australia, Bayer Healthcare, Lilly-Icos and Pfizer
(c) an innovative debate sponsored by the Journal of Sexual Medicine
(d) podium presentations of a selection of free papers on research and
management in sexual medicine and men’s health.
Various aspects of sexual dysfunction in both men and
women were comprehensively addressed. The relevance and significance of
erectile dysfunction in multi-system endothelial disease were emphasised.
The role and impact of sex therapy and of oncology on sexual function
and dysfunction were highlighted. Iatrogenic factors in sexual
dysfunction were deliberated and the place of complementary medicine,
pertinent particularly to the Asia Pacific region, was discussed.
The Abstracts of all the presentations were included
in the Book of Program & Abstracts prepared for the Meeting delegates
and are available at the Society’s website. They will be published in a
Supplement of the Journal of Sexual Medicine.
In addition to the great variety of social,
recreational and cultural opportunities available in Cairns and its
precincts, the Social Programme of the Meeting, with the Opening
Ceremony, Welcome Reception, Gala Dinner at the Tjapukai Aboriginal
Theme Park, and invitation-only Faculty Dinner at the Red Ochre, was
exciting and memorable.
The Meeting was generously supported by Bayer
Healthcare, Eli Lilly, Pfizer, American Medical Systems, Johnson &
Johnson, Schering and Mentor, with sponsorships, displays and social as
well as educational activities.
From the feedback received, the Meeting earned the
approval of all concerned and was a resounding success.
Some Highlights from the 10th
APSSM Meeting
Adapted from slides for ‘Daily Highlights’ prepared by Stephen Adams,
Sudhakar Krishnamurti and Warrick White.
Lifestyle
Factors in Erectile Dysfunction
- Studies suggest that
heart-healthy lifestyle changes reduce the risk of erectile
dysfunction (ED)
- Cardiovascular disease,
physical inactivity, obesity, smoking, alcohol intake and TV
viewing time are related to ED
- Regular physical activity is
correlated with a 30% reduced risk for ED
- Males without chronic medical
conditions and who regularly participate in healthy activities
have the lowest risk of ED
- Heart health is equivalent to
erectile health
- Drug therapy and lifestyle
changes are synergistic in ED
- Goal is increased quality and
quantity of life, not just ED treatment
|
PDE5
Inhibition: Applications Beyond Male Erectile Dysfunction
- Other potential uses:
– Pulmonary arterial hypertension
– Congestive heart failure?
– Female sexual dysfunction?
– Altitude performance problems?
– Embolic stroke?
- Pilot study: sildenafil may
be as effective as alpha blockers in lower urinary tract
symptoms (LUTS)?
|
The
Metabolic Syndrome
- Has a complex environmental
and genetic aetiology related to obesity and insulin resistance.
Incidence is growting.
- Predicts the development of
diabetes as well as cardiovascular and chronic kidney diseases.
Erectile dysfunction (ED) is common and related to endothelial
dysfunction, obstructive sleep apnoea, sympathetic nervous
system activity, hypogonadism, neurpopathy.
- Initial therapy is caloric
restriction and exercise.
- ED improves with lifestyle
measures, continuous positive air pressure therapy and
phosphodiesterase - 5 inhibitors, all of which also improve
endothelial dysfunction.
|
Snapshots from the Cairns Meeting
 |
 |
| The President,
President-Elect & Secretary-General at EXCO Meeting in Cairns. |
The Chair of
Organising Committee of
the 10th APSSM Meeting speaks. |
 |
 |
Starting a fire at
the Tjapukai Aboriginal
Theme Park. |
Happy faces! |
 |
| Happy
faces! |
2nd Regional APSSM Scientific Meeting and
1st AGASSI* Conference
The 2nd Regional
Scientific Conference of the APSSM will be held concomitantly with the
1st AGASSI (www.agassi.in) Conference at the Hilton Towers, Mumbai,
India, on
December 2nd and 3rd 2006. A live pre- or post-conference operative
workshop is being considered.
AGASSI is a new multi-disciplinary
society which deals with sexual medicine, both clinical and basic, in
addition to allied sub-specialties.
Formed with the support of experts and
professionals from both within and outside India, AGASSI hopes to become
the flagship academic platform for sexual medicine and
other allied sub-specialties in the Indian sub-continent. It hopes to
eventually affiliate itself with similar regional and international
societies.
An interesting scientific program is
being planned, and some leading international experts have already
confirmed their participation. The aim of this event is to make the
Regional Scientific Conference an important scientific and academic
APSSM event and to kick-start and promote AGASSI.
Mumbai is a well-connected city and
has already hosted many large international medical conferences in the
past. In addition, it is also the hub for tourism to other parts of
India.
For further information or expression
of interest, please access www.apsir.org or www.agassi.in, or email the
undersigned at:
andrologist@gmail.com.
Dr. Sudhakar Krishnamurti
(andrologist@gmail.com)
Organising Chairman
2nd Regional Scientific APSSM and 1st AGASSI Conference
www.sudhakarkrishnamurti.com
* The Ageing, Gender, Andrology &
Sexual Sciences
Society of India
Reports of 2004 APSSM Research Grant
Awardees
Due to space constraints,
only the salient aspects of each report are published. Further details
may be obtained from the awardees concerned through the Scientific &
Research Committee.
• Effects of combined treatment
with antioxidant and gene transfer on erectile function of rats with
generalised atherosclerosis
– Soo Woong Kim
Hypotheses:
1. Intracavernosal injection of cDNA
of type 2 dimethylarginine dimethylaminohydrolase-2 (DDAH-2) will lead
to an increase in the expression of DDAH-2 in treated rats.
2. Antioxidant therapy will lead to
an increase in DDAH activity in treated rats.
3. Combined treatment may lead to a
decrease in cavernosal asymmetric dimethylarginine (ADMA)
accumulation.
4. If the above assumptions prove
correct, the atherosclerotic rats will show a restoration in erectile
function due to increased cavernosal nitric oxide synthase (NOS)
activity.
Results/Conclusion:
Combination treatment of DDAH-2 gene transfection with vitamin E
supplement resulted in amelioration of erectile dysfunction by
diminishing ADMA levels and increasing NOS activity. Results
demonstrated that DDAH-2 gene expression combined with measures to
reduce oxidative stress may be a favourable therapeutic strategy to
treat erectile
dysfunction.
- A randomised, double-blind,
parallel-group, placebo-controlled study evaluating the physiologic
changes and safety of 20mg tadalafil administered every other day for
144 hours compared to placebo in healthy subjects with or without
visual sexual stimulation
– Jong Kwan Park
Method:
Ten healthy males were enrolled in the study, 5 were treated with 20mg
of tadalafil (group I) and had visual stimulation 90 minutes after
medication and the other 5 were treated with 20mg of tadalafil but did
not have visual stimulation (group II). Blood was sampled before
medication, and 1, 2, 4, 8, 24, and 36 hours after medication. Analyses
were conducted on blood pressure and pulse rates, the plasma cyclic
guanosine monophosphate (cGMP), cyclic adenosine monophosphate (cAMP),
atrial natriuretic peptide and aldosterone.
Results/Conclusion:
Cyclic GMP but not cAMP was increased 1, 2, 4, 8, 24, and 36 hours after
medication of tadalafil 20mg. There were no statistical differences
between the 2 groups.
- Effect of oestrogens on
intracellular cAMP and cGMP pathways in rat erectile tissue –
Srilatha Balasubramaniam
This study evaluated the effect of
oestrogens compared with testosterone (T) on intracellular cAMP and cGMP
levels in order to understand the specific effect of oestrogen(s) on
these final mediators of male erectile pathophysiology.
Specifically, this project studied the
intracellular release of cAMP and cGMP in the presence of T, oestradiol
(E2) and the dietary phytoestrogen daidzein to delineate the impact of
hormonal derangement on the cellular changes of erectile dysfunction
(ED).
The results indicated statistically
significant modulations in the cavernosal cAMP (increase) and cGMP
(decrease) by E2/daidzein while testosterone significantly enhanced cGMP
release. This study explains the cellular mechanism for the potential
aetiological role of oestrogen in ED.
Together with the androgen decline
manifesting as reduced libido and erectile impairment, the elevated
oestradiol per se in aging may further compound ED; similar changes
could be expected from inadvertent dietary intake of phytoestrogens.
- Age-related changes of nitric
oxide synthase isoforms and endothelin-1 in rat corpus cavernosum
– Hyun Jun Park, Bu Kyung Park, Nam Cheol Park
Purpose of Study:
Relaxation of penile cavernous smooth muscle, which is the primary
process in penile erection, is controlled by endothelial derived
substances. This study was designed to determine whether aging resulted
in altered endothelial autocrine/paracrine function.
Results/Conclusion:
The activation of vascular endothelin cascade and alterations in
expression of NOS isoforms may play an important role in age-dependent
vasculogenic erectile dysfunction.
- Novel animal model of Peyronie's
Disease by tunical injection of autologous blood – Bae JH, Moon
DG, Kim YS, Kim JJ
Purpose:
The production of fibrous plaque in tunica albuginea (TA) of rabbits is
attempted as a potential animal model of Peyronie's disease (PD).
Results/Conclusion:
Autologous blood can induce a reliable PD-like condition in the rabbit
model. With further refinement, an autologous blood-induced animal model
may be used as an experimental model for PD.
- The role of haeme oxygenase-1 in
artificially induced low-flow priapism in rat penile tissues – Jae
Seog Hyun, Sae Min Choi and Sung Chul Gam
Purpose:
In order to investigate role of haeme oxygenase (HO)-1 in a low-flow
priapism model, the expression and activity of HO-1 were examined in
artificially induced veno-occlusive priapism in rat penile tissues.
Results/Conclusion:
A higher induction of HO-1 with time was observed in artificially
induced veno-occlusive priapism; this may play a protective role against
hypoxic injury and importantly, may also play a critical role in the
vicious circle observed in low flow priapism.
A New Direction in Sexual Medicine:
Lifestyle Diseases and Erectile Dysfunction
Based on a presentation by the Editor at the Japanese Society for Sexual
Medicine/Pfizer Japan Symposium in Tokyo on 15th September 2005.
Lifestyle factors have brought about
considerable changes in the epidemiology of disease in the global
community and in the pattern and level of health risk for the
individual. Diet, exercise, cigarette smoking, alcohol and recreational
drugs are known to have serious implications in male sexual function in
addition to their well-documented association with a wide range of
morbidities.
A diet high in calories and saturated
fats readily leads to weight gain, which is often made worse by the
compounding effect of low physical activity encouraged by advances
in automation technology. In Australia, 67.4% of men over the age of 25
years are overweight with a body mass index (BMI) of ≥25, and 19.1% are
obese (BMI ≥30).1
Obesity, probably more aptly measured
by the waist circumference or the waist/hip ratio,2
is the most prominent and physically visible component of the Metabolic
Syndrome.
Pathophysiologically, the Metabolic
Syndrome is characterised by a decrease of tissue sensitivity to the
action of insulin, with consequently compensatory hyperinsulinaemia.
This leads to various permutations of obesity, type 2 diabetes mellitus,
dyslipidaemia and cardiovascular disease. Statistical data in Australia
show that, among men aged 25
years and older, 8.7% have diabetes mellitus (type 1 and 2), 51.5% have
hypercholesterolaemia (>5.5 mmol/L), and 32.3% have high blood pressure
(≥140/90 mm.Hg).1
Male sexual dysfunction comprises
erectile dysfunction (ED) and disorders of libido, ejaculation and
orgasm. As many risk factors are common to both cardiovascular disease
and male sexual dysfunction, particularly ED,3,4
and as the Metabolic Syndrome is
significantly implicated in the pathogenesis of cardiovascular
disease,2,5 it is conceivable that ED would be prevalent in men with the
various clinical components of the Metabolic Syndrome.
A decline in libido in men may be
related to decreased plasma testosterone levels associated with obesity
and sleep apnoea. Retrograde, retarded and absent ejaculation may be
attributable to the Metabolic Syndrome through, for instance, the
development of diabetic autonomic neuropathy and the use of medications.
As well as being significantly
implicated in cardiovascular disease,2,5 obesity and dyslipidaemia are
associated with a higher prevalence of ED.6,7
There is now mounting evidence that endothelial dysfunction associated
with the Metabolic Syndrome constitutes the pathophysiological basis of
most vasculogenic ED. Stratifying the levels of C-Reactive Protein
(CRP), a marker of systemic vascular inflammation, in patients with the
Metabolic Syndrome, diabetes mellitus or obesity has been shown to
enhance the predictive or prognostic information regarding their risk
for ED.9,10
In Australia, 21.1% of men aged 25
years and older smoke cigarettes and tobacco products, and smoking is
responsible for the greatest disease burden in Australia, accounting for
12% in Australian men.1 Although there are decreasing numbers of smokers
over recent years, of concern is the finding that most smokers are now
in the younger age groups. 82.4% of Australians drink alcohol, but only
8.3% are daily drinkers. Excessive alcohol consumption is a major risk
factor for morbidity and mortality. It is difficult to accurately assess
the level of use of recreational drugs.
A study on ED in general medical
practice had previously been conducted in Perth, Western Australia.11 A
community-based Western Australia Men’s Health Study was recently
concluded with its major focus on ED and its socio-demographic and
clinical correlates.12
Based on the 5-item International
Index of Erectile Function (IIEF-5) scores, the prevalence of ED among
West Australian males in the community aged 20 years and older was found
to be 25.4% (IIEF-5 <22), and 8.7% had severe ED (IIEF-5 <8). The
results of both studies confirmed yet again the significant correlation
of ED with cardiovascular disease, diabetes mellitus and cigarette
smoking.
Strategies have to be planned and
opportunities seized to address and modify lifestyle factors in the
preventive and therapeutic management of sexual dysfunction in general
and ED in particular.
The Asian EDACT Committee of the APSSM
The Asian Erectile Dysfunction Advisory Council and Training (EDACT)
Group, having accomplished its mission for a decade, will henceforth
continue to function as the EDACT Committee within the Asia Pacific
Society for Sexual Medicine (APSSM).
With the publication of the 11th
Issue, the InformED is now officially the APSSM Newsletter.
Further educational activities are
being considered and will be reported in these pages.
Asian EDACT Mission Statement
To develop Asian-specific programmes to help improve awareness,
understanding and management of erectile dysfunction, and to enhance
quality of life of patients with erectile dysfunction.
Asian EDACT Members
Dato’ Tan Hui Meng, Kuala Lumpur
Choi Hyung Ki, Seoul
Chen Kuang-Kuo, Taipei
Denis Cherry, Perth
Yasusuke Kimoto, Fukuoka
Sudhakar Krishnamurti, Hyderabad
Akmal Taher, Jakarta
Apichat Kongkanand, Bangkok
Benjamin Mendoza, Manila
Zhu Ji Chuan, Beijing
Li Man Kay, Singapore
Young Chan Kim, Seoul
Yip Wai-Chun, Hong Kong
Akihiko Okuyama, Osaka
|
Upcoming Meetings |
| MEETING |
DATE
|
VENUE
|
WEBSITE |
|
2006 |
| AUA Annual Meeting
2006 (with pre-AUA – 1st World Chinese Urological Society
Meeting) |
20–25 May |
Atlanta
USA |
www.aua2006.org |
1st Japan-ASEAN
Men’s Health and Aging Conference
– in conjunction with the 2nd National Men’s Health and
Aging Conference |
15–18 June |
Kuala Lumpur
Malaysia |
MH2006@console.com.my |
2nd Congress of the
Indonesian Association of Sexology
– 1st International Symposium on Sexual Medicine |
10–13 August |
Surabaya
Indonesia |
andrologisoetomo@yahoo.com |
12th World Congress
of the International Society for
Sexual Medicine |
17–21 September
|
Cairo
Egypt |
www.issm2006.info |
| 2nd Asia-Pacific
Forum on Andrology |
19–23 October |
Shanghai
China |
www.conference.ac.cn/APFA.htm |
| “From Babies to
Blokes”: The Making of Men |
29 October
-1 November |
Fremantle
Western Australia |
admin@man.org.au |
| 2nd APSSM Regional
Scientific Meeting – 1st AGASSI 2– Conference |
3 December |
Mumbai
India |
www.sudhakarkrishnamurti.com |
|
2007 |
| 4th Congress of the
Asia Pacific Society for the Study of the Aging Male |
24–27 January |
Bali
Indonesia |
apssam2007@urologi.or.id |
XVIII World Congress
of World Association for Sexual
Health – 1st World Congress for Sexual Health |
15–19 April |
Sydney
Australia |
www.sexo-sydney-2007.com |
| 11th Biennial
Meeting of the Asia Pacific Society for Sexual Medicine
|
30 September
-4 October |
Jeju
Korea |
Apssir2007@meci.co.kr |
References
1. Australian Institute of Health and Welfare 2004.Australia’ Health
2004. Ed Magnus P, Choi C, Madden R. Canberra. AIHW Cat. No. AUS 44.
2. Welborn TA, Dhaliwal SS, Bennett SA. Waist-hip ratio is the
dominant risk factor predicting cardiovascular death in Australia.
Med J Aust 2003; 179(11-12): 580-5.
3. Roth A, Kalter-Leibovici O, Kerbis Y, et al. Prevalence and risk
factors for erectile dysfunction in men with diabetes, hypertension,
or both diseases: a community survey among 1412 Israeli men. Clin
Cardiol 2003; 26:25-30.
4. Kawanishi Y, Lee KS, Kimura K, et al. Screening of ischaemic
Herat disease with cavernous artery blood flor in erectile
dysfunctional patients. Int J Impot Res 2001; 13:100-3
5. Walczak MK, Lokhandwala N, Hodge MB, et al. Prevalence of
cardiovascular risk factors in erectile dysfunction. J Gend Specif
Med 2002; 5:19-24.
6. Wei M, Macera CA, Davis DR, et al. Total cholesterol and high
density lipoprotein cholesterol as important predictors of erectile
dysfunction. Am J Epidemiol 1994; 140(10):930-7.
7. Feldman HA, Goldstein I, Hatzichristou G, et al. Impotence and
its medical and psychosocial correlates: results of the
Massachusetts Male Aging study. J Urol 1994; 151:54-61.
8. McVary KT, Carrier S, Wessells H, et al. Smoking and erectile
dysfunction: evidence base analysis. J Urol 2001; 166:1624-32.
© Adis Data Information BV 2006. No part of this publication may be
reproduced by any process in any language without written consent of
the publisher. The opinions expressed in this publication are not
necessarily those of the publisher or sponsor. Although great care
has been taken to ensure that the information in this publication is
accurate, neither the publisher nor the sponsor shall be held
responsible or in any way liable for the continued accuracy of the
information, or for any errors, omissons or inaccuracies, or for any
APS05-1848 consequences arising therefrom. Disclaimer: It is hereby
categorically declared that the opinion and views expressed in the
APSSM Newsletter do not necessarily represent those of the
Society or of the Editor. Neither the Society nor the Editor will be
responsible for any loss or damage on account of any action taken by
any person or group of persons as a result of any material published
in the Newsletter.
9. Giugliano F, Esposito K, Di Palo C, et al. Erectile dysfunction
associates with endothelial dysfunction and raised proinflammatory
cytokine levels in obese
men. J Endocrinol Invest 2004; 27(7):665-9.
10. Malik S, Wong ND, Franklin S, et al. Cardiovascular disease in
U.S. patients with metabolic syndrome, diabetes, and elevated
C-reactive protein. Diabetes Care 2005; 28(3):690-3.
11. Chew KK, Earle CM, Stuckey BGA, et al. Erectile dysfunction in
general medical practice: prevalence and clinical correlates. Int J
Impot Res 2000; 12:41-45.
12. Chew KK, Stuckey BGA, Earle CM, et al.The prevalence of erectile
dysfunction in Western Australia. J Sexual Med 2004; 1
(Suppl.1):31-2. |
Click here to download the News
Bulletin --> PDF 1.1Mb
|